West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$360.43 USD
-7.75 (-2.10%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $360.42 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Price, Consensus and EPS Surprise
WST 360.43 -7.75(-2.10%)
Will WST be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for WST based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for WST
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
WST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Conmed (CNMD) Surpasses Q1 Earnings and Revenue Estimates
Will West Pharmaceutical (WST) Beat Estimates Again in Its Next Earnings Report?
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
Other News for WST
Decoding West Pharmaceutical Services Inc (WST): A Strategic SWOT Insight
ResMed Inc's Meteoric Rise: Unpacking the 12% Surge in Just 3 Months
West Pharmaceutical Services: Strong Q1 Performance and Upbeat FY24 Outlook Bolster Buy Rating
West Pharmaceutical’s Key Decisions and Director Elections at Annual Meeting
West Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...